Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin.
Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.
Differential effect of baclofen on cortical and spinal inhibitory circuits.
High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: A case report and brief review of literature.
Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica.
Evaluating cognitive rehabilitation in multiple sclerosis: on the bumpy road to establishing evidence.
Development of a high-resolution fat and CSFsuppressed optic nerve DTI protocol at 3T: application in multiple sclerosis.
[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats].
Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.
Anti-JC virus antibody titres increase over time with natalizumab treatment.
Expert recommendations to personalization of medical approaches in treatment of Multiple Sclerosis: an overview of family planning and pregnancy.
Vitamin D status and the risk of multiple sclerosis: A systematic review and meta-analysis.
Going Against the Tide - How Encephalitogenic T Cells Breach the Blood-Brain Barrier.
Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis.
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis.
FTY720 protects neuronal cells from damage induced by human prion protein by inactivating the JNK pathway.
Interferon Beta and Glatiramer Acetate Therapy.
Pulmonary Hypertension and Multiple Sclerosis - Coincidence or Association?
Robot Training of Upper Limb in Multiple Sclerosis: Comparing Protocols With or WithoutManipulative Task Components.
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.
Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial.
Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6.
Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis.
Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
211
212
213
214
215
216
217
218
219
…
next ›
last »